对45种治疗精神分裂症的增强药物的综合评估:一个网络元分析
Damien Etchecopar-Etchart1,2,3, Dong Keon Yon4,5, Piotr Wojciechowski6
1UR3279, CEReSS, Research Centre on Health Services and Quality of Life, Aix Marseille University, Marseille, France.
EClinicalMedicine
|February 15, 2024
概括
这项网络元分析发现,几种增强性药物,包括西,美曼丁和米诺环素,在接受RISPERIDONE治疗的精神分裂症患者中显著改善了负面症状. 杜洛西丁在克洛扎治疗患者的负面症状方面表现有前途.
科学领域:
- 精神病学和药理学 精神病学和药理学
- 基于证据的医学基于证据的医学.
- 临床试验分析
背景情况:
- 精神分裂症的治疗依赖于抗精神病药物,但许多患者经历了持续的症状.
- 需要有效的增强策略对于改善患者的治疗结果至关重要.
- 这项研究解决了当前精神分裂症管理中的疗效差距.
研究的目的:
- 进行网络元分析,评估精神分裂症增强药物的疗效.
- 为了确定特定的药物和症状领域,增强显示显著益处.
- 为了比较不同背景抗精神病治疗方案的疗效.
主要方法:
- 搜索了多个数据库 (PubMed,科学网等) 从开始到2023年5月.
- 仅包括具有偏差低风险的双盲随机对照试验 (ROB2工具).
- 使用随机效应模型进行贝叶斯网络元分析,根据背景抗精神病药物 (risperidone,混合,clozapine) 分类.
主要成果:
- 在45种增强药物中,16种药物与安慰剂相比显示出显著的疗效.
- 特洛皮塞特朗,美曼丁和米诺环类药物显示出对RISPERIDONE的负面症状有显著的疗效.
- 杜洛西丁在克洛扎治疗患者的负面症状中有效;酸在这个群体的积极症状中显示出有效性.
结论:
- 几种增强药物在精神分裂症的特定症状领域提供了显著的好处.
- 疗效因背景抗精神病治疗方案而异.
- 需要进一步验证才能将这些发现纳入临床指南.
更多相关视频
相关概念视频
01:28Drug Therapy
44
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
44
01:28Psychosis and Antipsychotic Drugs: Overview
255
The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic...
255
01:21Antipsychotic Drugs: Typical and Atypical Agents
201
Antipsychotic drugs are classified into first-generation (typical) drugs including phenothiazines; and second-generation (atypical) drugs. Chlorpromazine hydrochloride (Thorazine), a phenothiazine derivative, broadly impacts the central, autonomic, and endocrine systems. This drug, along with typical agents like haloperidol (Haldol), primarily works by antagonizing D2 receptors, thus reducing dopaminergic neurotransmission. However, typical antipsychotics can cause side effects such as sedation...
201
01:30Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
125
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
125
01:21Antipsychotic Drugs: Therapeutic Uses and Side Effects
209
Antipsychotic drugs primarily block dopamine and serotonin receptors and cholinergic, adrenergic, and histaminergic receptors, thereby reducing hallucinations and delusions in conditions like schizophrenia. However, they can trigger unwanted extrapyramidal effects such as dystonias, Parkinson-like symptoms, and tardive dyskinesia.
Despite these side effects, antipsychotics are used therapeutically for various purposes, including managing schizophrenia, preventing nausea and vomiting, curbing...
Despite these side effects, antipsychotics are used therapeutically for various purposes, including managing schizophrenia, preventing nausea and vomiting, curbing...
209
01:26Psychosis: Goals of Pharmacotherapy
130
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
130